Skin Microbiomes in 56 Contact-Sport Athletes and 25 Controls
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact paper measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 56 wrestlers and kickboxers (30 male, 26 female; mean age 18.2 years) and 25 non-athlete controls (13 male, 12 female; mean age 19.8 years). |
| Design | 2023–2024 cross-sectional skin-microbiome study using standardized sampling, DNA isolation, sequencing and bioinformatic analysis. |
| Comparator | Athletes versus non-athletes, males versus females, and wrestlers versus kickboxers. |
| Timepoint | Single sampling assessment; no longitudinal follow-up. |
| Key result | Relative-abundance profiles differed by sex and sport; Psychrobacter was 7.3 versus 0.4 and Staphylococcus 9.5 versus 18.5 in athletes versus controls. Several genera were found in about 30% of athletes but not controls. |
| Funding/conflict context | Funding and author conflicts were not stated in the PubMed abstract. |
What was actually measured?
Relative-abundance profiles differed by sex and sport; Psychrobacter was 7.3 versus 0.4 and Staphylococcus 9.5 versus 18.5 in athletes versus controls. Several genera were found in about 30% of athletes but not controls.
Sequencing shows community-pattern differences, not clinical infection, and genus associations should not be read as diagnoses in individual athletes.
The denominator defines the claim. A diagnostic case, a patch-test reaction, a material analysis, a microbiome profile and a controlled intervention answer different questions. None should be silently converted into another.
What the result does not prove
Small cross-sectional groups, multiple comparisons, relative-abundance data and no clinical-outcome follow-up limit causal and risk claims.
Temporal or anatomic alignment can strengthen an exposure hypothesis, but it does not automatically prove individual causation. Referral patterns, prior sensitization, friction, sweat, occlusion, cleaning products, adhesives, metals, rubber additives and equipment age may all shape the finding.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the paper’s conclusions, this interpretation or any product.
Keep the condition categories separate
Dryness, friction injury, irritant dermatitis, allergic contact dermatitis, infection and swelling are not interchangeable. Patch testing evaluates delayed contact allergy; it does not diagnose every rash or replace clinician judgment.
Rapid facial or throat swelling, breathing difficulty, spreading redness, drainage, fever, severe pain, widespread blistering or loss of function requires prompt medical assessment. Do not deliberately re-expose yourself to suspected equipment or chemicals.
Activity and exposure details worth documenting
- Exact equipment, surface, material, adhesive, cleaner, glove, shoe, strap or instrument touching the area.
- Location and shape of the skin change relative to the contact site.
- Time from exposure to symptoms, and what changed during rest or avoidance.
- Sweat, friction, pressure, wetness, occlusion, ultraviolet exposure and cleaning routines.
- Manufacturer material disclosures, workplace safety data and clinician-directed testing—not self-testing.
Prevention comes before cosmetic care
Prevention must match the hazard: fit and friction control, material substitution, protective equipment, engineering controls, occupational-health review and clinician-guided allergen avoidance. Never apply workplace or sports chemicals directly to skin to “test” them.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 41003594
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: contact dermatitis
- American Academy of Dermatology: dry-skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This paper did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, allergy, infection, blisters, sunburn or swelling; relieves pain or itch; neutralizes an allergen; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Cosmetic Intolerance and Patch Tests in 132 Opera-House Artistes
- Acetophenone-Azine Allergy From Hockey Shin Pads in One Player
- Exercise-Related Itch and Skin Sensitivity in 401 Young Adults
- Six-Month Sunscreen Intervention in 234 German Outdoor Workers
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation, product-safety determination or occupational clearance.